Indrayani Biotech Ltd (INDRANIB) is currently trading at 7.86 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Indrayani Biotech Limited, incorporated in 1992, initially focused on horticulture products like cut flowers and hybrid seeds. Its current core business is the manufacture of electric motors and distribution of electrical apparatus. The company has undergone several strategic shifts and restructurings, including significant equity reduction and mergers, transforming from agriculture to industrial manufacturing. Historically, Indrayani faced ecological challenges affecting its agricultural operations, which prompted shifts in its business model towards more sustainable pursuits. Recent ventures into subsidiary incorporation and business amalgamations indicate a strategic intent to diversify and strengthen its operational capabilities and market presence.

Over the past 52 weeks, Indrayani Biotech Ltd has traded between a low of ₹6.69 and a high of ₹18.05. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Indrayani Biotech Ltd has a market capitalization of approximately 62.45. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Indrayani Biotech Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 23.48 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 62.45 Cr, Indrayani Biotech Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Indrayani Biotech Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Indrayani Biotech Ltd is 23.48. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Indrayani Biotech allotted 83,64,036 rights equity shares. This included 75,03,333 fully paid shares and 8,60,703 partly paid shares.

The record date is April 28, 2026, as stated in the issue details.

Indrayani Biotech reported a consolidated net profit of ₹2.16 crore for FY26, versus a consolidated net loss of ₹6.11 crore in FY25.

The company cited delays in consolidating subsidiary results and completing audit processes, and said the board meeting would be held at a later date.